Clinical Trial Update: Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating gabapentin to reduce radiation therapy-induced pain during treatment of oropharyngeal cancer has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Henry Ford Health System | Conditions: Oropharynx Cancer | Phase 3 | Status: COMPLETED | Results posted: 2022-01-20